Aristeia Capital’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,500,000
| Closed | -$1.04M | – | 585 |
|
|
2020
Q4 | $1.04M | Sell |
1,500,000
-6,100,000
| -80% | -$4.21M | 0.03% | 222 |
|
|
2020
Q3 | $17.1M | Buy |
7,600,000
+3,843,728
| +102% | +$8.65M | 0.7% | 29 |
|
|
2020
Q2 | $13.4M | Sell |
3,756,272
-1,468,728
| -28% | -$5.26M | 0.69% | 21 |
|
|
2020
Q1 | $19.9M | Sell |
5,225,000
-366,743
| -7% | -$1.39M | 1.68% | 12 |
|
|
2019
Q4 | $16.8M | Buy |
+5,591,743
| New | +$16.8M | 1.11% | 16 |
|